These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 808886)

  • 21. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
    Chan WK; Horvath TD; Tan L; Link T; Harutyunyan KG; Pontikos MA; Anishkin A; Du D; Martin LA; Yin E; Rempe SB; Sukharev S; Konopleva M; Weinstein JN; Lorenzi PL
    Mol Cancer Ther; 2019 Sep; 18(9):1587-1592. PubMed ID: 31209181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA fragmentation in N-diazoacetylglycine amide-treated cells determined, by the rate of strand separation in alkali with hydroxylapatite chromatography in batch.
    Maura A; Grillo Ruggieri F; Cavanna M
    Boll Soc Ital Biol Sper; 1981 Jun; 57(11):1282-6. PubMed ID: 6793046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of L-asparaginase preparations of E. coli and agouti serum on the homograft reactivity in the mouse.
    Schulten HK; Giraldo G
    Recent Results Cancer Res; 1970; 33():155-9. PubMed ID: 4949159
    [No Abstract]   [Full Text] [Related]  

  • 24. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
    Rosenfeld H; Roberts J
    Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of serum L-asparagine in the presence of L-asparaginase requires the presence of an L-asparaginase inhibitor.
    Asselin BL; Lorenson MY; Whitin JC; Coppola DJ; Kende AS; Blakley RL; Cohen HJ
    Cancer Res; 1991 Dec; 51(24):6568-73. PubMed ID: 1742729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylococcal L-asparaginase: antilymphoma and immunosuppressive action.
    Sobiś M; Mikucki J; Lisiecki P
    Acta Microbiol Pol; 1991; 40(3-4):137-42. PubMed ID: 1726614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The trypanocidal effect of the cleavage products of berenil in acid solution and the possibility of their in vivo recoupling in NMRI mice (author's transl)].
    Raether W; Loewe H; Seidenath H
    Tropenmed Parasitol; 1974 Sep; 25(3):273-82. PubMed ID: 4432277
    [No Abstract]   [Full Text] [Related]  

  • 28. Antimetastatic effects of N-diazoacetyl-glycine derivatives in C57BL mice.
    Giraldi T; Nisi C; Sava G
    J Natl Cancer Inst; 1977 Apr; 58(4):1129-30. PubMed ID: 403295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-asparaginase-induced immunosuppression: effects on antibody-forming cells and serum titers.
    Chakrabarty AK; Friedman H
    Science; 1970 Feb; 167(3919):869-70. PubMed ID: 4903650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-asparaginyl-tRNA synthetase and L-asparagine synthetase activities of L-asparaginase-sensitive and -resistant forms of the mouse Gardner lymphoma 6C3HED.
    Davies MR; Lambert LP; Marshall RD
    Clin Sci (Lond); 1979 Jan; 56(6):539-45. PubMed ID: 38936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diazo derivatives of amino acids and peptides as possible antineoplastic chemotherapeutic agents. XII. Experimental antineoplastic activity of hydrazone derivatives of N-diazoacetylglycine hydrazide].
    Brambilla G; Baldini L; Cavanna M
    Boll Soc Ital Biol Sper; 1966 Nov; 42(22):1675-8. PubMed ID: 5982442
    [No Abstract]   [Full Text] [Related]  

  • 32. [Inhibition of lymphocyte transformation in the diffusion-chamber ("in vivo") by L-asparaginase].
    Pappas A; Hirschmann WD; Scheurlen PG; Esser W
    Med Welt; 1970 Jul; 28():1288-91. PubMed ID: 5508100
    [No Abstract]   [Full Text] [Related]  

  • 33. [Research in vitro on the mechanism of action of N-diazoacetylglycine ethyl ester].
    Brambilla G; Baldini L; Del Vivo M
    Boll Soc Ital Biol Sper; 1966 Nov; 42(22):1682-4. PubMed ID: 5982444
    [No Abstract]   [Full Text] [Related]  

  • 34. Preliminary in vivo evaluation of the protein transduction domain-modified ATTEMPTS approach in enhancing asparaginase therapy.
    Li YT; Kwon YM; Spangrude GJ; Liang JF; Chung HS; Park YJ; Yang VC
    J Biomed Mater Res A; 2009 Oct; 91(1):209-20. PubMed ID: 18814276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytostatic effect of L-asparaginase].
    Rakowska-Wódz A; Szyszka K; Abucewicz A
    Wiad Lek; 1970 Jan; 23(2):117-20. PubMed ID: 4985374
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of amino acid depletion in combined treatment of neoplastic cells with methotrexate and L-asparaginase.
    Chlopkiewicz B; Koziorowska J
    Cancer Res; 1975 Jun; 35(6):1524-9. PubMed ID: 805660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of metastases by L-asparaginase in allogeneic and isogeneic mouse tumor systems.
    Deodhar SD
    Adv Exp Med Biol; 1973; 29(0):519-25. PubMed ID: 4604432
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunosuppressive action in mice of diazoacetylglycine amide and diazoacetylglycine hydrazide in compairison to methotrexate].
    Baldini L; Brambilla G; Cavanna M; Parodi S
    Boll Soc Ital Biol Sper; 1968 Mar; 44(5):441-3. PubMed ID: 5674631
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of blastogenesis by native and polyethylene glycol-modified asparaginases from Escherichia coli and Vibrio succinogenes.
    Bendich A; Kafkewitz D; Abuchowski A; Davis FF
    Immunol Commun; 1983; 12(3):273-84. PubMed ID: 6350165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppressive action of L-asparaginase.
    Emmerling P; Finger H
    Ger Med Mon; 1971; 1(1):21-3. PubMed ID: 4931501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.